EVP, Chief Financial Officer Lakkaraju Roop Kalyan converted options into 1,077 units of Bio-Rad A Common Stock and covered exercise/tax liability with 386 units of Bio-Rad A Common Stock, increasing direct ownership by 448% to 845 units (SEC Form 4)